Clinical Trial Update: Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of metformin in myotonic dystrophy type 1 (Steinert's disease) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Steinert's Disease, Myotonic Dystrophy 1 | Phase 3 | Status: RECRUITING